Media Kits

Media members may access multimedia resources such as fact sheets, infographics, photos, logos, select press releases and more, all for use in stories in development.

Neutralizing Antibodies for COVID-19

See More About Antibody Therapies

Baricitinib for COVID-19

See More About Baricitinib

Cyramza® (ramucirumab) Approved by the U.S. FDA as First-Line Treatment for Metastatic EGFR-Mutated Non-Small Cell Lung Cancer

Read More About Cyramza

Retevmo® (selpercatinib): First Therapy Specifically for Patients with Advanced RET-Driven Cancers Is Approved

Read More About Retevmo

woman teaching a girl to ride a bike

Reyvow™ (lasmiditan) C-V: A First-in-Class Acute Treatment for Migraine Is Now Available

Read More About Reyvow